<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhang H</submitter><funding>Chinese Ministry of Science and Technology | Department of S and T for Social Development (Department of S&amp;T for Social Development)</funding><funding>China Postdoctoral Science Foundation</funding><funding>National Natural Science Foundation of China (National Science Foundation of China)</funding><pagination>1021-1036</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12689640</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>35(12)</volume><pubmed_abstract>Activation of the μ-opioid receptor (μOR) alleviates pain but also elicits adverse effects through diverse G proteins and β-arrestins. The structural details of μOR complexes with G&lt;sub>z&lt;/sub> and β-arrestins have not been determined, impeding a comprehensive understanding of μOR signaling plasticity. Here, we present the cryo-EM structures of the μOR-G&lt;sub>z&lt;/sub> and μOR-βarr1 complexes, revealing selective conformational preferences of μOR when engaged with specific downstream signaling transducers. Integrated receptor pharmacology, including high-resolution structural analysis, cell signaling assays, and molecular dynamics simulations, demonstrated that transmembrane helix 1 (TM1) acts as an allosteric regulator of μOR signaling bias through differential stabilization of the G&lt;sub>i&lt;/</pubmed_abstract><journal>Cell research</journal><pubmed_title>The molecular basis of μ-opioid receptor signaling plasticity.</pubmed_title><pmcid>PMC12689640</pmcid><funding_grant_id>32141004</funding_grant_id><funding_grant_id>2024M752856</funding_grant_id><funding_grant_id>82271001</funding_grant_id><funding_grant_id>2019YFA0508800</funding_grant_id><funding_grant_id>92353303</funding_grant_id><funding_grant_id>32430051</funding_grant_id><pubmed_authors>Yang G</pubmed_authors><pubmed_authors>Shen Q</pubmed_authors><pubmed_authors>Ji SY</pubmed_authors><pubmed_authors>Dong Y</pubmed_authors><pubmed_authors>Zhu Y</pubmed_authors><pubmed_authors>Qin J</pubmed_authors><pubmed_authors>Zhang H</pubmed_authors><pubmed_authors>Yang M</pubmed_authors><pubmed_authors>Zang SK</pubmed_authors><pubmed_authors>Chen LN</pubmed_authors><pubmed_authors>Wu H</pubmed_authors><pubmed_authors>Zhao M</pubmed_authors><pubmed_authors>Guo J</pubmed_authors><pubmed_authors>Xi K</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Yu T</pubmed_authors><pubmed_authors>Wang X</pubmed_authors><pubmed_authors>Xue J</pubmed_authors><pubmed_authors>Shen DD</pubmed_authors></additional><is_claimable>false</is_claimable><name>The molecular basis of μ-opioid receptor signaling plasticity.</name><description>Activation of the μ-opioid receptor (μOR) alleviates pain but also elicits adverse effects through diverse G proteins and β-arrestins. The structural details of μOR complexes with G&lt;sub>z&lt;/sub> and β-arrestins have not been determined, impeding a comprehensive understanding of μOR signaling plasticity. Here, we present the cryo-EM structures of the μOR-G&lt;sub>z&lt;/sub> and μOR-βarr1 complexes, revealing selective conformational preferences of μOR when engaged with specific downstream signaling transducers. Integrated receptor pharmacology, including high-resolution structural analysis, cell signaling assays, and molecular dynamics simulations, demonstrated that transmembrane helix 1 (TM1) acts as an allosteric regulator of μOR signaling bias through differential stabilization of the G&lt;sub>i&lt;/</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Dec</publication><modification>2026-07-15T06:36:44.457Z</modification><creation>2026-06-30T03:23:41.451Z</creation></dates><accession>S-EPMC12689640</accession><cross_references><pubmed>41199005</pubmed><doi>10.1038/s41422-025-01191-8</doi></cross_references></HashMap>